• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    19-Oxygenated steroid compounds of the pregnane series of the formula I <IMAGE> (I) in which R1 represents a hydrogen atom, and R2 represents an alpha -oriented lower alkanoylthio group, or R1 and R2 together represent a carbon-carbon bond or an alpha -or beta -oriented methylene radical, R3 represents a free hydroxymethyl group or a hydroxymethyl group etherified by a lower alkyl or esterified by a lower alkanoyl; or represents a formyl group, a carboxyl group or a lower alkoxycarbonyl group, and R4 represents a hydrogen atom or the acyl radical Ac of a carboxylic acid, and corresponding 1,2-dehydro derivatives have valuable aldosterone-antagonizing properties with a minimum effect on sexual functions. As the compounds reduce the excessive sodium retention and potassium excretion induced by aldosterone, they are especially useful as the active ingredient in pharmaceutical preparations for alleviating diseases involving hyperaldosteronismus in man and other warm-blooded animals.
    公开号:SU786906A3
    申请号:SU782618095
    申请日:1978-05-29
    公开日:1980-12-07
    发明作者:Биоллац Михель
    申请人:Циба-Гейги Аг (Фирма)；
    IPC主号:
    专利说明:

    f 2. - “(.- oriented lower alkanoylthio group, followed by hydrolysis or esterification, if necessary,
    Tetraalkylammonium hydroxide, alkali metal or alkaline earth metal alcoholate, alkali, alkali metal carbonate are preferably used as the base. Of the acids, preferably protic acids (hydrohalic acids, sulfuric and perchloric acids, organic sulfonic acids) and Lewis acids {boron trifluoride are used. or boron trifluoride etherate, as well as medium-strength carboxylic acids (oxalic, formic and thioacetic acid).
    Isomerization is preferably carried out in an anhydrous aprotic solvent with a catalytic amount of acid or base. ,
    Alkanthioacid addition is preferably carried out by heating and, if necessary, by irradiation with ultraviolet light.
    The compounds of the formula T are aldosterone antagonists: they increase the excretion of sodium and contribute to the preservation of potassium in the body, and therefore can be used as diuretics.
    Example 1. To a solution of .100 mg of 19, 21-dioxy-17 ° (β-pregna-4,6-diene-3, 20-DION-19,21-diacetate in 2.5 ml of ethanol were added 0.25 ml of concentrated salt It is heated to boiling temperature for 30 minutes. The volatile components of the reaction mixture are removed by evaporation in vacuo, the residue is dissolved in 1 ml of pyridine and treated with 0.5 ml of acetic anhydride. After cooling for 17 hours at room temperature, the mixture is evaporated in vacuo, the residue is dissolved in ethylene acetate, washed successively with 1N hydrochloric acid, dilute sodium bicarbonate solution and again with water, dried with sodium sulfate, and the solvent is distilled off. The residue is chromatographed on a silica gel column, eluted with hexane-ethyl acetate-acetone (12: 2: 1), first a small portion of the regenerated starting material and then the main fraction 19.21 -dioxy-pregna-4, b-diene 3,20-dione-19, 21-diacetate, mp.152154C (methylene chloride-ether).
    Similarly, starting from the corresponding 17-O1-compound, 21-hydroxy-19-methoxypreg-4, b-diene-3,20-dione-21 acetate can also be obtained, mp 159-1b1 C, .Jg + 176 (with 0.5 chloroform).
    The original substance 17- "A-predicated row is obtained as follows
    a) From 34 g of potassium and 980 ml of tert.-butanol in an argon atmosphere, a solution of tert, -potassium potassium butylate is prepared and a solution of 45 g of 3,3-ethylenedithio-18-oxyandrosta-4 is quickly added dropwise to it, b -diene-17-one in 100 ml of 1,2-dimethoxyethane at room temperature under argon atmosphere. After stirring for 15 minutes, a solution of 35.5 g of tosylmethyl isocyanide in 100 of 1,2-dimethoxyethane is poured into the reaction mixture for 90 minutes at 25.degree. C., the mixture is stirred for an additional 1 hour and poured into ice-water. The organic layer is separated, the aqueous layer is extracted with methylene chloride, the combined organic extracts are washed with water, dried with sodium sulfate and evaporated in a vacuum created by a water-jet pump. The residue is chromate, grafted on a column of silica gel, eluted with a mixture of hexane-ethylene acetate
    . (4: 1) and get 24 g of 3,3-ethylenedithio-17o {.-Cyanoandrost-4, b-diene-19-ol with so pl.180-181 ° C after a single recrystallization from smosi
    methylene chloride-diisopropyl eLir; Go Zche + 162 ° (s o, 14; chloroform). Re-elution with a mixture of solvents gives 12 g of 3,3-ethylenedithio-17o (-cyanoandrost-4, 6-diene-19-ol with mp 211-213 ° C (methylene chloride-ethyl acetate); SD1 61 Ds 0.48 chloroform).
    b) To a solution of 24 g of 3,3-ethylenedithio-17c4. cyanoandrost-4, 6-diene-19-ol in 450 ml of 1,2-dimethox 1 Ethane is added dropwise in the course of 15 minutes and under stirring 400 ml of a 20% aqueous solution of diisobutylaluminum hydride, then heated to and stirred at this temperature for another 1 hour. The product is dissolved in methylene chloride, the organic phase is alternately washed with water, aqueous sodium bicarbonate solution, again with water, dried with sodium sulfate and evaporated in vacuo, created using a water jet pump. The residue is chromatographed on a silica gel column. By eluting with a mixture of toluene-ethyl acetate (95: 5), 3, 3-ethylenedithio-19-oxyandrosta-4, 6-diene-17 1-carbaldehyde is obtained.
    c) A solution of 6.7 ml of formaldehyde dimethylthioacetal-5-oxide in 80 ml of tetrahydrofuran is treated under argon at 13.5 ml of 1.6N. a solution of butyl lithium in hexane, added it dropwise so that the temperature does not exceed -17 °. Then a solution of 13 g 3, 3-ethIlenthio-19-oxyandrost-4, b-diene-171-carbaldehyde in 100 ml of tetrahydrofuran for 30 min and stirred still
    30 min. The reaction mixture was poured into water mixed with ice, and the product was dissolved in ethyl acetate. United organic extracts PRO
    Wash alternately with water and saturated sodium chloride solution, dry with sodium sulfate, evaporate in vacuo and residue is chromatographed on a silica gel column. After elution with a mixture of hexane and ethyl acetate (1: 1), the unsaturated starting material is regenerated, and then fractions with ethyl acetate-acetone (2: 1) elute the fractions, which after distillation of the solvent are a crystalline isomeric mixture of 3,3-ethylenedithio-21 | -methylsulfinyl-21 -methylthio-17o-pregna-4, 6-diene-19, 20 | -diol, which is further processed without separation.
    d) To a solution of 15., 9 g of a mixture of isomers obtained according to item c),
    in 960 ml of acetone, 42 ml of water, 12 g of mercury chloride (P) and
    12 g of cadmium carbonate, stirred for 5 hours at room temperature and filtered on suction through a layer of diatom seg-shi. The residue on the filter is extracted with methylene chloride, the extract is combined with the original filter and evaporated. The resulting non-isodic mixture of isomeric 19,20-dioxy-21-methylsulfinyl-21 | -methio-17sz (.-Pregna-4, 6-diene-3-ones is processed directly in the next stage.
    e) The isomer mixture of step d) is dissolved in 300 ml of tetrahydrofuran, 50 ml of 5N are added to it. hydrochloric acid and stirred for
    13h at room temperature. The reaction mixture is poured into 2 liters of water mixed with ice, and the product is dissolved in methylene chloride. The combined extracts are washed alternately with dilute sodium carbonate solution, water and sodium chloride solution, dried with sodium sulfate and evaporated in vacuo. The residue is chromatographed on a silica gel column; by elution with a hexane-acetone (2: 1) mixture, 19,21-dioxy-17o1. -pregna-4,6-diene-3,20-dione is obtained.
    Example 2 A solution of 1.4 g of 19,21-dioxypregna-4,6-diene-3, 20-dione-19, 21-diacetate prepared according to Example 1 in 80 ml of methanol is mixed with a solution of 1 g of sodium bicarbonate in 20 ml of water, then stirred for 4 h under argon at room temperature and concentrate in vacuo. The organic phase is separated, washed with sodium chloride solution, dried over sodium sulfate and evaporated.
    Chromatography on silica gel and elution with a mixture of hexane-ethyl acetate (1: 1) gave 19,21-dioxypregna-4,6-diene-3, 20-dione-19-acetate, which after repeated dissolution in methylene chloride-isopropyl ether melts at SO -UZ S.
    Example 3. A solution of 211 mg of sodium bicarbonate in 2.6 ml of water was added to a solution of 100 mg of 19,21-dioxypregna-4,6-diene-3, 20-di-diacetate in 6.5 ml of methanol and boiling for 3 hours. reflux and concentrate in vacuo. A solution of the residue in methylene chloride is washed with 15%
    - an aqueous solution of sodium chloride, dried with sodium bicarine and evaporated in vacuo. The residue is dissolved in a mixture of hexane-ethyl acetate (1: 1) and chromatographed on silica gel. The product after evaporation of the solvent
    - recrystallized from a mixture of methylene chloride-ether-diisopropyl ether, and get 19,21-dioxypregna-4, 6-diene-3, 20-dione with so pl.161 ".
    0 under the same conditions and with the same weight and volume amounts as described above, this target product is obtained from the following c, the corresponding esters: 19-monoacetate,
    5 21-monoacetate, 21-mono-pivalate, 19-acetate-21-pivalat at, 19-acetate-21.-valerianate, 19-acetate-21-benzoate, 19-formate-21-benzoate, 19-butyrate-21-acetate and 19,21-dibutyrate.
    Q Example 4. A solution of 500 mg of 19,21-dioxypregna-4,6-diene-3, 20-dione-19-acetate in 14 ml of methanol and 0.8 ml of thioacetic acid is refluxed for
    1 h, cooled to room temperature and water is added to it until the solution becomes cloudy. The reaction mixture is evaporated in vacuum at a temperature not higher than 45 ° C to dryness and the residue is chromatographed on silica gel. Elution with a mixture of hexane-acetone (4: 1) gives a chromatographically pure 7c-acetylthio-19, 21-dioxypregn-4-ene-3,20-LION-19-acetate, which is obtained by lyophilization from aqueous methanol in an amorphous state. IR spectrum (in methylene chloride): 3469,2950,1740,1690, 1670, 1625, 1385,1365,1255,1335,1230,1120,1080, 1040,955,910 CM-l
    Similarly, from 21-hydroxy-19-methoxypregna-4, 6-diene-3, 20-dione-21-acetate, 7 ° are obtained (.- acetylthio-21-oxy-19-methoxypreg-4-en-3, 20-dione 21-acetate in an amorphous state (drops out of
    aqueous methanol) fo (. 78 (with 0.5, chloroform).
    IR (methylene chloride): 2950, 1745,1720,1690,1670,1720,1275,1360, 1235,1120,1085,965 cm
    Example 5. To a solution of 286 mg
    19,21-dioxypregna-4,6-dien-3, 20-dione-19-acetate in 3 ml of pyridine was added 1.5 ml of benzoyl chloride, kept at room temperature for 30 minutes and dried in
    water mixed with ice
    权利要求:
    Claims (1)
    [1]
    The formula of the invention
    - hydrogen, lower alkyl or lower alkanoyl;
    8d - hydrogen or alkanoyl with
    .. 1-7 carbon atoms;
    dashed line means a possible double bond, characterized in that 17c (. is an isomeric compound of the general Formula COCH 2 OR 4 40
    D
    45 θ J where R4, R J., R a, and R ^ have the above meanings, are reacted with a strong base or acid and, if necessary, the obtained compound of formula T, where R 4 and ^ 2 together is a carbon-carbon bond, is treated lower alkanethioic acid to obtain compounds of formula 1, where - hydrogen and R 2 ~ - ^ .- oriented lower alkanoyl55 thio group, followed by hydrolysis or esterification, if necessary.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU786906A3|1980-12-07|Method of preparing pregnane derivatives
    WO1991001994A1|1991-02-21|11β-SUBSTITUTED 16α,17α-METHYLENE-ESTRA-4,9-DIENE-3-ONES
    RU2168516C2|2001-06-10|Steroid with 17-spiromethylenelactone group and method of its synthesis
    PT1831239E|2010-05-06|A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid lambda-lactone and key-intermediates for this process
    US3682983A|1972-08-08|Preparation of {66 {11 {11 -17 ethinyl steroids
    Rosenkranz et al.1952|Steroids. XXIX. 1 Synthesis of 11β-Hydroxyprogesterone
    US4789671A|1988-12-06|14,17β-ethano-14β-estratrienes and estratetraenes, process for their production, and pharmaceutical preparations containing them
    Hassner et al.1962|The Cleavage Reaction of 16-Oximino-17-keto Steroids1
    SU942601A3|1982-07-07|Process for producing corticosteroids
    US3170934A|1965-02-23|Unsaturated 19-oxygenated 3-oxosteroids and process for their manufacture
    US3210388A|1965-10-05|13alpha-fluoro-17beta-methyl-18-nor steroids
    SU679147A3|1979-08-05|Method of producing dextorotatory homosteroids
    US3032552A|1962-05-01|1-methyl steroids of the androstane series
    US2713061A|1955-07-12|3-methyl androstanes
    JPH075629B2|1995-01-25|Novel steroid compound and pharmaceutical composition containing the same
    DE1793618C3|1975-10-23|03/07/63 USA 263441 Process for the production of 3-hydroxy-1,5-bisdehydrosteroids of the androstane series
    US3072686A|1963-01-08|16alpha-alkyl-pregnane compounds and process for their manufacture
    US3255218A|1966-06-07|17|-enol-21-aldehydes of the pregnane series
    US4136179A|1979-01-23|2,2-dimethyl-19-nor-steroids
    US4203981A|1980-05-20|Novel 17 α-aryl-steroids
    JPH10511379A|1998-11-04|14α, 17α-C 2) Crosslinked 19-nor-progesterone derivative
    US3079408A|1963-02-26|Ig-bisoxygenated iy-haloestra-
    HERZIG et al.1952|INVESTIGATIONS ON STEROIDS. XVII. DEHYDRATION STUDIES IN THE SERIES OF 3β, 5, 19-TRIHYDROXYETIOCHOLANIC ACID
    US4078059A|1978-03-07|Novel 2,2-dimethyl steroids
    NUMAZAWA et al.1986|Regiospecific deoxygenation of the dihydroxyacetone moiety at C-17 of corticoid steroids with iodotrimethylsilane
    同族专利:
    公开号 | 公开日
    IL54805A|1982-11-30|
    ATA393178A|1981-06-15|
    US4309423A|1982-01-05|
    ES470282A1|1979-09-16|
    NO781884L|1978-12-01|
    ES478126A1|1979-05-16|
    HU181861B|1983-11-28|
    ZA783125B|1979-06-27|
    IT7849581D0|1978-05-29|
    SE7806244L|1978-12-01|
    FI781628A|1978-12-01|
    DD140146A5|1980-02-13|
    NZ187431A|1980-05-27|
    GB1603675A|1981-11-25|
    PH14606A|1981-10-02|
    LU77457A1|1979-01-19|
    ES478127A1|1979-05-16|
    DK240078A|1978-12-01|
    FR2405712A1|1979-05-11|
    GR71594B|1983-06-17|
    FR2405712B1|1982-09-10|
    IL54805D0|1978-07-31|
    FR2405958A1|1979-05-11|
    BE867634A|1978-11-30|
    FR2405958B1|1982-01-15|
    PT68095A|1978-06-01|
    FR2408623B1|1982-03-05|
    ES478128A1|1979-05-16|
    PL207237A1|1979-06-04|
    JPS53149964A|1978-12-27|
    CA1114367A|1981-12-15|
    AU520330B2|1982-01-28|
    AT365609B|1982-02-10|
    DE2823239A1|1978-12-14|
    NL7805632A|1978-12-04|
    AU3665078A|1979-12-06|
    ES478125A1|1979-05-16|
    FR2408623A1|1979-06-08|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DE1146651B|1956-07-28|1963-04-04|Giuseppe Giusi|Feed gearbox for machines for cutting out round disks from plastic sheets, especially button washers|
    US3039926A|1958-10-10|1962-06-19|Pfizer & Co C|19-hydroxy pregnenes|
    CH425774A|1961-07-14|1966-12-15|Ciba Geigy|Process for the production of 19-nor-steroids|
    GB1041534A|1963-04-24|1966-09-07|Merck & Co Inc|20-spiroxane compounds|
    US3493564A|1968-02-29|1970-02-03|American Home Prod|2,19-epoxy-delta4,6-steroids and intermediates for their synthesis|
    BR6915132D0|1969-04-02|1973-02-08|Ciba Geigy|PROCESS FOR OBTAINING DELTA 4 6-OR DELTA 5 6-3-OXO-19-NOR-STEROIDS|
    US3849404A|1973-03-09|1974-11-19|Searle & Co|Purification of 6,7-dihydro-17-hydroxy-3-oxo-3'h-cyclopropa-17alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactones|
    CA1049498A|1973-11-29|1979-02-27|Gunther Kruger|Steroid compounds and processes therefor|
    JPS6212237B2|1977-03-17|1987-03-17|Mitsubishi Chem Ind|MA18433A1|1978-05-26|1979-12-31|Ciba Geigy Ag|PROCESS FOR THE SYNTHESIS OF THE HYDROXYACETYL SIDE CHAIN OF PREGNAGNE-TYPE STEROIDS, NEW 21-HYDROXY-20-OXO-17 ALPHA-PREGNAGNES AND PHARMACEUTICAL PRODUCTS CONTAINING|
    US4261985A|1978-11-22|1981-04-14|Ciba-Geigy Corporation|Novel diuretics|
    US5002940A|1984-11-06|1991-03-26|Ciba-Geigy Corporation|Solid drug formulations and stable suspensions|
    US4659704A|1985-05-21|1987-04-21|Ramot University Authority For Applied Research & Industrial Development Ltd.|19-hydroxyaldosterone and its preparation|
    FR2656309B1|1989-12-22|1992-05-07|Roussel Uclaf|NEW STEROUID PRODUCTS COMPRISING IN POSITION 10, A SUBSTITUTED ETHYL RADICAL, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.|
    FR2676740B1|1991-05-23|1993-11-05|Roussel Uclaf|NOVEL STEROUID DERIVATIVES OF PREGNA-4,9 , 17-TRIE-3-ONE, THEIR PREPARATION, THEIR APPLICATION TO THE PREPARATION OF PREGNA-4,9 , 16-TRIENE- STEROUID COMPOUNDS 3.20-DIONE AND NEW INTERMEDIATES.|
    DE4433374A1|1994-09-20|1996-03-21|Hoechst Ag|17-deoxi-corticosteroid-21- / O / -carboxylic acid ester, process for their preparation and medicaments containing them|
    PT1325022E|2000-09-18|2006-12-29|Applied Research Systems|Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone |
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    LU77457A|LU77457A1|1977-05-31|1977-05-31|
    [返回顶部]